[The place of citicolin in pulmonological therapy (author's transl)].
Citicolin, a psychodrug, is usually used for the treatment of ischemic cerebropathies. Its introduction into pulmonological therapy is suggested because Citicolin has the following properties: 1. Prevention of "acute respiratory distress syndrome" in neonates. 2. Improvement of chronic respiratory insufficiency. 3. Prevention of postoperative hypoventilation syndrome. 4. Improvment of respiratoy mechanics in syndromes with hyperelasticity of the lungs. 5. Recovery of permeability of the alveolo-capillary barrier for gases. 6. Compensation of the loss of surface-active substances after endobronchial aspiration of intubated patients.
D000818:Animals; D002794:Choline / Q000031:analogs & derivatives*; D003566:Cytidine Diphosphate Choline / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008055:Lipids / Q000096:biosynthesis; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D010743:Phospholipids / Q000096:biosynthesis; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000517:prevention & control; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013499:Surface Properties
D008055:Lipids; D010743:Phospholipids; D011663:Pulmonary Surfactants; D003566:Cytidine Diphosphate Choline; D002794:Choline
Citicolin in der pulmonologischen Therapie